ANAVEX2-73 oral liquid

Drug identity checked against registry records

Also recorded as Blarcamesine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeNCT04304482AVXLPhase 2, Phase 3Completed2023-06-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.